HCW Biologics is trading 12.73% higher at $1.24, with broader market strength potentially contributing to the gain.

  • The S&P 500, Nasdaq Composite and Dow are each up more than 0.5%.
  • No company-specific announcement dated November 2, 2026, appears in the company’s news-release listing; its latest listed release is dated October 9.
  • No specific company catalyst or live trading-volume figure was verified.